• Sanders, B. P., de los Rios Oakes, I., van Hoek, V., Bockstal, V., Kamphuis, T., Uil, T. G., Song, Y., Cooper, G., Crawt, L. E., Martín, J., Zahn, R., Lewis, J., Wimmer, E., Custers, J. H. H. V., Schuitemaker, H., Cello, J. & Edo-Matas, D. 2016. Cold-Adapted Viral Attenuation (CAVA): Highly Temperature Sensitive Polioviruses as Novel Vaccine Strains for a Next Generation Inactivated Poliovirus Vaccine. PLoS Pathog, 12, e1005483. PubMed Abstract
  • Dunn, G. 2016. Quality Assurance in the Polio Laboratory. Cell Sensitivity and Cell Authentication Assays. In: MARTÍN, J. (ed.) Poliovirus: Methods and Protocols. New York, NY: Springer New York. PubMed Abstract
  • Minor, P. D. 2016. An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication. In: MARTÍN, J. (ed.) Poliovirus: Methods and Protocols. New York, NY: Springer New York. PubMed Abstract
  • Fatima, A., Ivanyuk, D., Herms, S., Heilmann-Heimbach, S., O’Shea, O., Chapman, C., Izsvák, Z., Farr, M., Hescheler, J. & Šarić, T. 2016. Generation of human induced pluripotent stem cell line from a patient with a long QT syndrome type 2. Stem Cell Research, 16, 304-307. PubMed Abstract
  • Longstaff, C., Hogwood, J., Gray, E., Komorowicz, E., Varjú, I., Varga, Z. & Kolev, K. 2016. Neutralisation of the anti-coagulant effects of heparin by histones in blood plasma and purified systems. Thrombosis and Haemostasis, 115, 591-599. PubMed Abstract
  • Abou-El-Enein, M. & Schneider, C. K. 2016. Deciphering the EU clinical trials regulation. Nat Biotech, 34, 231-233. PubMed Abstract